New study aims to tailor breast cancer treatment for patients over 70

NCT ID NCT07273357

Recruiting now Knowledge-focused Sponsor: Region Jönköping County Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 breast cancer patients aged 70 and older who are starting a type of targeted therapy called CDK4/6 inhibitors combined with hormone therapy. The goal is to see how well geriatric screening tools can predict side effects and quality of life changes. Researchers hope to better understand the benefits and risks of this treatment in older adults, who are often underrepresented in clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADJUVANT DRUG THERAPY BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) GERIATRIC ASSESSMENT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Oncology
RECRUITING

Gävle, Sweden

Contact Email: •••••@•••••
Department of Oncology
RECRUITING

Jönköping, 55312, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Oncology
RECRUITING

Kalmar, Sweden

Contact Email: •••••@•••••
Department of Oncology
RECRUITING

Linköping, Sweden

Contact Email: •••••@•••••
Department of Oncology
NOT_YET_RECRUITING

Örebro, Sweden

Contact Email: •••••@•••••